(Reuters) - Ophthotech Corp said it could potentially receive over $1 billion in payments as part of a licensing deal for its experimental eye drug with Novartis AG. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/gLol4w490m8/story01.htm
Read More
No comments:
Post a Comment